Effect of clobenpropit, a centrally acting histamine H3-receptor antagonist, on electroshock- and pentylenetetrazol-induced seizures in mice

Journal of Neural Transmission

Volumn 105, Issue 6-7, 1998, Pages 587-599

  Fischer, W ^a   Van Der Goot, H ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Anticonvulsants; Clobenpropit; Electroconvulsive threshold; H3 receptor antagonists; Histamine; Pentylenetetrazol; Seizure models; Thioperamide

Indexed keywords

ALPHA METHYLHISTAMINE; CARBAMAZEPINE; CLOBENPROPIT; HISTAMINE H2 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; PENTETRAZOLE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; ATAXIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTRIC SHOCK; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SEIZURE THRESHOLD;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; CARBAMAZEPINE; DIFFERENTIAL THRESHOLD; ELECTROSHOCK; HISTAMINE ANTAGONISTS; IMIDAZOLES; MALE; MICE; MOTOR ACTIVITY; PENTYLENETETRAZOLE; SEIZURES; THIOUREA; VALPROIC ACID;

EID: 0031665004     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050081     Document Type: Article

References (51)

1. Arrang J-M (1994) Pharmacological properties of histamine receptor subtypes. Cell Mol Biol 40: 275-281
2. 3) of histamine receptor. Nature 302: 832-836
3. 3-receptors. Nature 327: 117-123
4. 3-receptor: pharmacology, roles and clinical implications studied with agonists. In: Timmerman H, van der Goot H (eds) New perspectives in histamine research. Birkhäuser, Basel Boston Berlin (Agents Actions [Suppl 33]: 55-67)
5. 3 receptor antagonist. Eur J Pharmacol 250: 147-152
6. 3-receptor subtypes. Br J Pharmacol 107: 919-923
7. Dunham NW, Miya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46: 208-209
8. Fairbairn S, Sturman G (1989) The influence of central histaminergic modification on the susceptibility of mice to chemically-induced seizures. Br J Pharmacol 97 [Suppl]: 319P
9. Gerald MC, Richter NA (1976) Studies on the effects of histaminergic agents on seizure susceptibility in mice. Psychopharmacologia 46: 277-282
10. Haas HL, Greene RW, Reiner PB (1989) The brain histamine system in vitro. J Neurosci Meth 28: 71-75
11. Inagaki N, Yamatodani A, Ando-Yamamoto M, Tohyama M, Watanabe T, Wada H (1988) Organization of histaminergic fibers in the rat brain. J Comp Neurol 273: 283-300
12. Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA (1978) Antiepileptic drug development, II. Anticonvulsant drug screening. Epilepsia 19: 409-428
13. 3 receptor. In: Jucker E (ed) Progress in drug research. Birkhäuser, Basel Boston Berlin, pp 107-165
14. Litchfield Jr, JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99-113
15. Löscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2: 145-181
16. Löscher W, Fasshender CP, Nolting B (1991) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 8: 79-94
17. Martinez-Mir MI, Pollard H, Moreau J, Arrang JM, Ruat M, Traiffort E, Schwartz JC, Palacious JM (1990) Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Res 526: 322-327
18. Mochizuki T, Yamatodani A, Okakura K, Takemura M, Inagaki N, Wada H (1991) In vivo release of neuronal histamine in the hypothalamus of rats measured by microdialysis. Naunyn Schmiedebergs Arch Pharmacol 343: 190-195
19. 125I]iodophenpropit binding. Brain Res 743: 178-183
20. 3 antagonist, decreased seizure susceptibility of electrically induced convulsions in mice. Meth Find Exp Clin Pharmacol 17(C): 70-72
21. Onodera K, Yamatodani A, Watanabe T, Wada H (1994) Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Progr Neurobiol 42: 685-702
22. Panula P, Pirvola U, Auvinen S, Airaksinen MS (1989) Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28: 585-610
23. Panula P, Airaksinen MS, Pirvola U, Kotilainen E (1990) A histamine-containing neuronal system in human brain. Neuroscience 34: 127-132
24. Pollard H, Schwartz J-C (1987) Histamine neuronal pathways and their functions. Trends Neurosci 10: 86-89
25. Sangalli B (1997) Role of the central histaminergic neuronal system in the CNS toxicity of the first generation H1-antagonists. Progr Neurobiol 52: 145-157
26. Scherkl R, Hashem A, Frey H-H (1991a) Importance of histamine for seizure susceptibility. In: Timmerman H. van der Goot (eds) New perspectives in histamine research. Birkhäuser, Basel Boston Berlin (Agents Actions [Suppl 33]: 85-89)
27. Scherkl R, Hashem A, Frey H-H (1991b) Histamine in brain - its role in regulation of seizure susceptibility. Epilepsy Res 10: 111-118
28. 3 heteroreceptors. Fundam Clin Pharmacol 8: 128-137
29. Schwartz J-C (1988) Histamine receptors in brain. ISI Atlas Sci: Pharmacology 185-189
30. Schwartz J-C, Arrang J-M, Garbarg M (1986) Three classes of histamine receptors in brain. Trends Pharmacol Sci 7: 24-28
31. 3-receptor. Agents Actions 30: 13-23
32. Schwartz J-C, Arrang J-M, Garbarg M, Pollard H, Ruat M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71: 1-51
33. Shiraishi J, Wada Y, Nakamura M, Koshino Y (1996) Role of histaminergic system in kindled generalized seizures. Epilepsia 37 [Suppl 3]: 113
34. 3-receptor antagonist thioperamide in rats. II Farmaco 52: 457-462
35. 3-receptor antagonists. Drugs Fut 21: 507-520
36. Sturman G, Freeman P (1992) Histaminergic modulation and chemically-induced seizures in mice. Agents Actions 36 [Special Conference Issue]: C358-C360
37. 3-histamine receptors and chemically-induced seizures in mice. Agents Actions 41 [Special Conference Issue]: C68-C69
38. Tuomisto L, Tacke U (1986) Is histamine an anticonvulsive inhibitory transmitter? Neuropharmacol 25: 955-958
39. 3 receptor: a general presynaptic histaminergic regulatory system? Trends Pharmacol Sci 10: 159-162
40. Wada H, Inagaki N, Yamatodani A, Watanabe T (1991) Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci 14: 415-419
41. White JM, Rumbold GR (1988) Behavioural effects of histamine and its antagonists: a review. Psychopharmacology 95: 1-14
42. Wyngaarden JB, Seevers MH (1951) The toxic effects of antihistaminic drugs. J Am Med Assoc 145: 277-283
43. 3 receptor antagonist, increases GABA release from the rat hypothalamus. Methods Find Exp Clin Pharmacol 19: 289-298
44. Yamatodani A, Inagaki N, Panula P, Itowi N, Watanabe T, Wada H (1991) Structure and functions of the histaminergic neurone system. In: Uvnäs (ed) Histamine and histamine antagonists. Springer, Berlin Heidelberg New York, pp 243-283 (Handbook of experimental pharmacology, vol 97)
45. Yokoyama H, Iinuma K (1996) Histamine and seizures. Implications for the treatment of epilepsy. CNS Drugs 5: 321-330
46. Yokoyama H, Onodera K, Maeyama K, Yanai K, Iinuma K, Tuomisto L, Watanabe T (1992) Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of α-fluoromethylhistidine and metoprine. Naunyn Schmiedebergs Arch Pharmacol 346: 40-45
47. 3 receptor antagonist, on electrically induced convulsions in mice. Eur J Pharmacol 234: 129-133
48. 3-antagonists on electrically-induced seizure in developing mice. Psychopharmacology 112: 199-203
49. 3 receptor antagonist, inhibits electrically induced convulsions in mice. Eur J Pharmacol 260: 23-28
50. 1 agonist, decreased seizure susceptibility in mice. Pharmacol Biochem Behav 47: 503-507
51. 1 antagonists promote the development of amygdala kindling in rats. Neurosci Lett 217: 194-196